Diversin inhibitors belong to a class of chemical compounds that have gained significance in the field of molecular and cellular biology. These inhibitors are specifically designed to target and modulate the activity of Diversin, a protein involved in various cellular processes, particularly during embryonic development and tissue homeostasis. Diversin, also known as Dvl-binding protein (Diversin), plays a crucial role in the Wnt signaling pathway, a highly conserved and intricate molecular network that regulates processes such as cell fate determination, tissue development, and cell proliferation.
Diversin inhibitors exert their effects by interfering with the activity or function of Diversin, disrupting its role within the Wnt signaling cascade. This interference can lead to alterations in the transmission of Wnt signals, affecting cellular responses and developmental processes regulated by the pathway. Researchers employ Diversin inhibitors as valuable tools to investigate the specific functions and regulatory mechanisms of Diversin in different cellular contexts, particularly during embryonic development and tissue regeneration. Understanding the intricacies of Diversin's role in the Wnt signaling pathway is essential for advancing our knowledge of molecular and cellular biology related to development, tissue homeostasis, and the implications for diseases where Wnt signaling is dysregulated. While the precise applications and broader implications of Diversin inhibitors continue to be subjects of ongoing research, their utility in elucidating the complexities of Wnt signaling and its impact on cellular physiology and development is of paramount importance in advancing our understanding of molecular and cell biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Binds to GC-rich DNA sequences and may interfere with the transcription of certain genes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known to intercalate into DNA and RNA, potentially affecting gene expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Inhibits DNA topoisomerase II, potentially affecting transcription processes. | ||||||
Acridine Orange solution | 65-61-2 | sc-473594 | 10 ml | $166.00 | 2 | |
Intercalates into DNA and may disrupt nucleic acid function and gene expression. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Causes premature chain termination during translation, potentially decreasing protein levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA polymerase, which can decrease mRNA synthesis. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
A potent inhibitor of RNA polymerase II that could lower transcription levels of mRNA. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Binds to bacterial RNA polymerase and may inhibit mammalian RNA polymerase as well. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Inhibits DNA topoisomerase I, affecting DNA replication and transcription processes. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Intercalates into DNA strands and can disrupt transcription and replication mechanisms. | ||||||